Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The translocator protein 18 kDa (TSPO) ligand etifoxine in an animal model of anxiety: Line- and sex-dependent effects on emotionality, stress reactivity, spine density, oxytocin receptors, steroids, and microbiome composition.
Fischer L, Paschke B, Gareis F, Schumacher M, Liere P, Hiergeist A, Gessner A, Rupprecht R, Neumann ID, Bosch OJ. Fischer L, et al. Among authors: rupprecht r. Neuropharmacology. 2024 Dec 24;266:110282. doi: 10.1016/j.neuropharm.2024.110282. Online ahead of print. Neuropharmacology. 2024. PMID: 39725124 Free article.
Short-term effects of etifoxine on human gut microbiome in healthy men.
Manook A, Baghai TC, Riebel M, Nothdurfter C, Schwarzbach JV, Gessner A, Rupprecht R, Hiergeist A. Manook A, et al. Among authors: rupprecht r. Front Neurosci. 2023 Nov 14;17:1188847. doi: 10.3389/fnins.2023.1188847. eCollection 2023. Front Neurosci. 2023. PMID: 38075272 Free PMC article.
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS.
Riebel M, von Pappenheim B, Kanig C, Nothdurfter C, Wetter TC, Rupprecht R, Schwarzbach J. Riebel M, et al. Among authors: rupprecht r. Pharmacopsychiatry. 2023 Jul;56(4):154-161. doi: 10.1055/a-2078-4823. Epub 2023 May 23. Pharmacopsychiatry. 2023. PMID: 37220781 Clinical Trial.
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study.
Brunner LM, Riebel M, Wein S, Koller M, Zeman F, Huppertz G, Emmer T, Eberhardt Y, Schwarzbach J, Rupprecht R, Nothdurfter C. Brunner LM, et al. Among authors: rupprecht r. Trials. 2024 Apr 22;25(1):274. doi: 10.1186/s13063-024-08120-x. Trials. 2024. PMID: 38650030 Free PMC article. Clinical Trial.
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam.
Wein S, Riebel M, Seidel P, Brunner LM, Wagner V, Nothdurfter C, Rupprecht R, Schwarzbach JV. Wein S, et al. Among authors: rupprecht r. Neuropsychopharmacology. 2024 Oct;49(11):1738-1748. doi: 10.1038/s41386-024-01884-5. Epub 2024 May 31. Neuropsychopharmacology. 2024. PMID: 38822128 Free PMC article. Clinical Trial.
421 results